Jagsonpal Pharmaceuticals had announced a stock split in the ratio of 1:2.5 and fixed January 8 as the record date for determining the shareholder eligibility, which makes today the last day to buy the stock to qualify for the split offer.
“Pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors of the Company has passed the necessary resolution through Circular Resolution, on Tuesday, December 17, 2024 and has fixed the record date on Wednesday, January 8, 2025 for the purpose of Sub-division/Split of equity shares of the Company such that 1 (one) equity share having face value of Rs. 5/- (Rupees five only) each, fully paid-up, be sub-divided into such number of equity shares having face value of Rs. 2 (Rupee two only) each,” the company had said in a previous exchange filing.
Shareholders who buy the stock at least one day before the ex-date are eligible for the offers as settlement happens the next day. Those buying the stock on the ex-date are not eligible for dividends/splits/bonus issues etc.
After the implementation of the T+1 framework, the ex-date and record date usually fall on the same day (except if there is a stock market holiday on the record date).
Stock Trading
Masterclass on Value Investing and Company Valuation
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
By — Saketh R, Founder- QuickAlpha, Full Time Options Trader
Stock